Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Jan 10;15(1):e0226833. doi: 10.1371/journal.pone.0226833

Effects of Allium hookeri on gut microbiome related to growth performance in young broiler chickens

Sung-Hyen Lee 1,*,#, Sohyun Bang 2,#, Hwan-Hee Jang 1, Eun-Byeol Lee 1, Bong-Sang Kim 3, Seung-Hwan Kim 4, Sang-Hyun Kang 4, Kyung-Woo Lee 5, Dong-Wook Kim 6, Jung-Bong Kim 1, Jeong-Sook Choe 1, Shin-Young Park 1, Hyun S Lillehoj 7
Editor: Juan J Loor8
PMCID: PMC6953852  PMID: 31923247

Abstract

Healthy food promotes beneficial bacteria in the gut microbiome. A few prebiotics act as food supplements to increase fermentation by beneficial bacteria, which enhance the host immune system and health. Allium hookeri is a healthy food with antioxidant and anti-inflammatory activities. A. hookeri is used as a feed supplement for broiler chickens to improve growth performance. Although the underlying mechanism is unknown, A. hookeri may alter the gut microbiome. In the current study, 16S rRNA sequencing has been carried out using samples obtained from the cecum of broiler chickens exposed to diets comprising different tissue types (leaf and root) and varying amounts (0.3% and 0.5%) of A. hookeri to investigate their impact on gut microbiome. The microbiome composition in the groups supplemented with A. hookeri leaf varied from that of the control group. Especially, exposure to 0.5% amounts of leaf resulted in differences in the abundance of genera compared with diets comprising 0.3% leaf. Exposure to a diet containing 0.5% A. hookeri leaf decreased the abundance of the following bacteria: Eubacterium nodatum, Marvinbryantia, Oscillospira, and Gelria. The modulation of gut microbiome by leaf supplement correlated with growth traits including body weight, bone strength, and infectious bursal disease antibody. The results demonstrate that A. hookeri may improve the health benefits of broiler chickens by altering the gut microbiome.

Introduction

Diet plays an important role in modulating gut microbiome by providing food substrates for gut microorganisms [1,2]. Dietary components not digestible by host enzymes can be digested by gut bacteria [3]. For example, prebiotics such as inulin, polyphenol, and galacto-oligosaccharide are non-digestible food ingredients that promote the growth of beneficial bacteria [4]. Such prebiotics increase the fermentation products produced by beneficial bacteria, which enhances host immune response [5,6]. Elucidation of the interactions between diet and microbiome has raised the interest in functional foods with beneficial effects on gut microbiome and host health [7].

Among the various functional foods, Allium hookeri is widely used as a health food that treat high blood glucose or lipid levels in patients with diabetes mellitus in Korea [8,9]. A. hookeri belongs to the genus Allium, which includes A. cepa (onion) and A. sativum L. (garlic). Allium species have been used as medicinal foods to reduce the risk of several types of cancers by preventing mutagenesis [10]. The beneficial effects of Allium are attributed to the abundance of organosulfur compounds, polyphenols, and allicin [11,12]. A. hookeri contains six-fold higher levels of organosulfur than garlic, and higher cellulose and total phenol contents than onion [13]. As these components exhibit antioxidant activities, the use of A. hookeri is promising as a medical food [14,15]. A. hookeri exhibits immunomodulatory effects in lymphocytes, macrophages, and tumor cells in in-vitro chicken cell experiments [16]. In vivo experiments have also suggested that A. hookeri inhibits the inflammatory response in the pancreas of diabetic rats and LPS-induced young broiler chickens [17,18].

The beneficial effects of A. hookeri on health suggest its use in commercial animal farming including pigs and chickens [1921]. A. hookeri, when used as a feed supplement, enhanced the oxidative stability of pork and improved the growth performance of broiler chickens [22]. Although the mechanism of action is unclear it is suspected that A. hookeri alters the gut microbiome. A. hookeri components such as organosulfur compounds, polyphenols, and allicin are known to affect the gut microbiome by increasing or decreasing the bacterial composition [21,23,24]. Further, a previous study has reported that diets including onions belonging to Allium genus modulate gut microbiota and increase body weights of broiler chickens [25,26]. Thus, it has been hypothesized that A. hookeri alters the gut microbiome and that such changes might lead to beneficial growth effects in commercial animals. However, the collective effect of A. hookeri on gut microorganisms needs to be further elucidated.

The objective of this study was to determine the effect of A. hookeri on gut microbiome in chicken. We investigated the changes in the composition of gut microorganisms in chicken by feeding leaves and roots of A. hookeri. We sequenced 24 caecal samples derived from six groups of chickens (four samples each). The groups included chickens fed with individual diets containing 0.3% leaves, 0.5% leaves, 0.3% roots, and 0.5% roots. The effects of A.hookeri as a feed additive were evaluated by comparing the groups exposed to A. hookeri diet with the control group (Control) or commercial supplement (CS). We examined whether A. hookeri altered the composition of microorganisms, and determined their effect on growth performance in chickens.

Results

Effects of A. hookeri as a feed supplement on gut microbiome diversity

To elucidate the differences in microbiota exposed to different amounts of A. hookeri roots or leaves, a principal coordinate analysis (PCoA) based on weighted UniFrac metrics was performed (Fig 1). Samples within the leaf group were clustered at shorter distances compared with those in the other groups. Permutational Multivariate Analysis of Variance (PERMANOVA) was also used to determine the significant differences between groups. The variation between the six groups was observed (P-value < 0.05; Table 1). We also examined the effect of feeding with A. hookeri leaf and root on the composition of gut microorganisms by grouping the samples exposed to A. hookeri according to the tissue or amount. When we divided the samples exposed to A. hookeri leaves and roots irrespective of the amounts of A. hookeri, significant differences occurred between Control, CS, Leaf and Root. However, we did not find significant differences between Control, CS, 0.3% and 0.5%, when the samples were divided according to the amounts of A. hookeri.

Fig 1. A principal coordinate analysis (PCoA) plot showing dissimilarities among different diet groups.

Fig 1

PCoA from distance of weighted UniFrac. Each dot represents a single sample. “Leaf”, “Root”, “0.3”, “0.5” denote leaf, root of A. hookeri, 0.3%, and 0.5% diets, respectively.

Table 1. Results of PERMANOVA.

Test group r2 F-Ratio P-value
Tissue and amount of A. hookeri 0.27 1.34 0.016
Tissue of A. hookeri 0.17 1.44 0.011
Amount of A. hookeri 0.13 1.07 0.31

The groups exhibiting significant variation were subjected to PERMANOVA pair-wise tests as follows: (1) groups of ‘Tissue of A. hookeri’, and (2) ‘Tissue and amount of A. hookeri’. In the pair-wise test for (1), ‘Control, Root’ showed no significiant difference, although the difference between control groups and leaf was significant, with a low p-value (Table 2). In the pair-wise test for (2), pairs of groups exposed to the same tissues but different amounts (Leaf 0.3, Leaf 0.5 pair and Root 0.3, Root 0.5 pair) showed no significant difference (S1 Table), which suggested that the effect of 0.3% and 0.5% A. hookeri showed little difference as in-feed supplements. Combinations with Leaf 0.5 were significant with lower p-values than the other pair-wise combinations indicating that the abundance and variety of microorganisms in chickens exposed to leaf 0.5 differed from that of the control group.

Table 2. Results of PERMANOVA of pair-wise test for tissue groups.

Pair P-value Pair P-value
Control, CS 0.537 CS, Leaf 0.018
Control, Leaf 0.022 CS, Root 0.438
Control, Root 0.056 Leaf, Root 0.005

The diversity of microorganisms within a local community was evaluated based on diversity and richness using Shannon index and the observed operational taxonomic unit (OTU), respectively (S1 Fig). The diversity showed a similar distribution of Shannon index across combinations except for Leaf 0.3 and Root 0.3 compared with CS (P = 0.02). Richness also showed similar distribution across groups with ‘combinations of tissue and amount’ of A. hookeri (P = 0.083) except for Leaf 0.3 compared with CS (P = 0.02). Compared with the control, diversity and richness were not affected by diets supplemented with A. hookeri (P = 0.5). In summary, while the differences between chickens exposed to leaf and other groups showed better diversity, the differences within a local community were not apparent when compared with the control.

A. hookeri-associated microbiota changes

At the phylum level, Firmicutes and Bacteroidetes were the major groups of microorganisms in the cecum of chicken (Fig 2A), accounting for more than 80% and 10% of microorganisms, respectively. The amounts of most phyla including Firmicutes and Bacteoidetes showed no difference between supplements and Control or CS groups except for the composition of Cyanobacteria identified as Gastranaerophilales at the class level, which was decreased in Leaf 0.5 compared with that of the Control or CS. However, only limited information was available regarding the differences at the phylum level. Therefore, the differences in the abundance of microorganisms at the genus level were investigated.

Fig 2. Abundance of microorganisms at phylum and genus levels.

Fig 2

(a) Phylum level composition: Bar plots represent the percentage (%) of average abundance for groups. (b) Venn diagrams showing differential abundance of features at the genus level. (c) The Leaf group shows the relative abundance of different taxa.

Approximately 70% of the features exist at the genus level. The dominant genera in the samples are shown in S2 Fig. These features were associated with the differential abundance of microorganisms by comparing each A. hookeri supplement group with the Control or CS (FDR< 0.05). The chickens fed with the root supplement did not show differential abundance of taxa. However, a few genera were significantly associated with the gut microbiome of chickens exposed to Leaf compared with the Control or CS categories. Chickens fed with Leaf 0.5 showed seven different genera compared with the Control. Chickens exposed to Leaf 0.5 carried five genera compared with the CS. By contrast, chicken exposed to Leaf 0.3 showed only two different genera compared with the CS. Based on these findings, we concluded that only the Leaf supplement was associated with the abundance of microbial genera. The amounts of leaf supplement also altered the abundance of microorganisms.

The abundance of a few common genera varied in Control vs. Leaf 0.5, CS vs. Leaf 0.5, and CS vs Leaf 0.3. Parabacteriodes and Eubacterium nodatum group, which differed between chickens exposed to CS and Leaf 0.3 also varied in abundance in the Control and Leaf 0.5 groups. Most genera included in Leaf 0.5 compared with CS were also identified in Leaf 0.5 compared with Control. Eubacterium nodatum group, Marvinbryantia, Oscillospira, and Gelria species were common in both tests (Fig 2B). Significant and differentially abundant genera detected only in Leaf 0.5 compared with Control included Parabacteroides, Gastranaerophilaes, and NB1-n while the Christensenellacea R-7 group was found abundantly only in Leaf 0.5 compared with CS. We observed a decrease in the abundance of most of the genera except for Parabacteroides (Fig 2C). Eubacterium nodatum group showed almost undetected in chickens fed with Leaf 0.3 and Leaf 0.5. The abundance of Marvinbryantia, Gelria and NB1-n decreased gradually according to the amount of Leaf supplementation compared with their mean abundance in the Control. A rapid reduction in the levels of Oscillospira, Gastranaerophilales and Christensenellaceae R-7 group was observed in chickens exposed to Leaf 0.5.

Correlation between the abundance of microorganisms and growth traits

A. hookeri not only affects the microbiome composition, but also the growth traits such as body weight, bone strength, and levels of infectious bursal disease (IBD) antibody. These traits were linked to gut microbiome in several studies [27,28]. The abundance of genera was correlated with growth traits. Spearman’s rank correlation coefficients were significant for 7, 5, and 7 genera with body weight, bone strength, and IBD antibody, respectively (Spearman's rho; P-value < 0.05).

Among the seven genera correlating with body weight, Ruminococcaceae UCG-005 showed highly negative correlation with body weight (Spearman's rho = -0.56) (Fig 3A). Clostridium sensustricto 1 had the highest correlation with body weight (Spearman's rho = 0.44). The relative abundance of correlated genera was indicated next to the correlation index. The genera showing negative correlation with body weight had lower abundance in Leaf 0.3 and Leaf 0.5 categories while the genera displaying positive correlation with body weight showed relatively higher abundance in Leaf 0.3 and Leaf 0.5 groups. Thus, the relative abundance of microorganisms correlated with body weight is related to the specific Leaf diet.

Fig 3. Correlation between microbiota and growth performance including body weight, bone strength, and IBD antibody.

Fig 3

(a) Microorganisms showing significant correlation with body weight: The column in “corr” shows Pearson’s. r value. The heatmap represents the mean abundance of groups. (b) Microorganisms showed significant correlation with bone strength. (c) Microorganisms showed significant correlation with antibody titers against infectious bursal disease (IBD).

Most of the genera that correlated with bone strength were negative (Fig 3B). Most microorganisms that negatively correlated with bone strength showed a lower abundance in chickens fed with Leaf 0.5 compared with those in other groups. NB1-n genera showing negative correlation with bone strength (Spearman's rho = -0.43) were significantly lower in Leaf 0.5. However, Parasutterella only showed a highly positive correlation with bone strength (Spearman's rho = 0.74).

Seven microorganisms correlated with antibody titers against IBD, including three species that were negatively correlated and four that were positively correlated (Fig 3C). The Eubacterium brachy group showed the highest correlation (Spearman's rho = 0.57), showing increased abundance in Leaf 0.3 and Leaf 0.5 but uniformly lower abundance in other groups. Parasutterella was positively correlated with bone strength and with IBD antibody production. The abundance of Gelria was significantly decreased in chickens fed with Leaf 0.5 and showed a negative correlation with IBD antibody (Spearman's rho = -0.44). Exposure to Leaf 0.5 also resulted in a similar pattern of microbial abundance correlated with IBD antibody, with a higher (or lower) abundance in chickens fed with Leaf 0.5 showing positive (or negative) correlation with IBD antibody.

Prediction of gut microflora function

Microbial functions predicted by phylogenetic investigation of communities via reconstruction of unobserved states (PICRUSt) were compared between chickens exposed to Control and Leaf 0.5 because the genera correlating with growth traits were associated with their abundance in Leaf 0.5 (Fig 4). Among the 38 different functions analyzed, 30 were associated with a lower abundance and eight with a higher abundance in chickens fed with Leaf 0.5. Most higher functions in Leaf 0.5 were related to metabolism. Enriched functions of microorganisms in Leaf 0.5 group such as C5-branched dibasic acid metabolism, fructose and mannose metabolism, and galactose metabolism were included in carbohydrate metabolism. Most significantly, lysine degradation was depleted in Leaf 0.5. Among the functions depleted in chickens exposed to Leaf 0.5, the terms related to human disease were prevalent (S3 Fig). Especially, the functions of microorganisms depleted in Leaf 0.5 category related to pathways in cancer, renal cell carcinoma, colorectal cancer, and small cell lung cancer.

Fig 4. Predicted functions of microorganisms showing significant difference between Control and Leaf 0.5.

Fig 4

Functions were predicted using PICRUSt. Functions with significant difference (P < 0.05, one sided Wilcoxon rank sum test) are shown. The error bar represents SD (standard deviation). The upper box shows functions enriched in Leaf 0.5 compared with control while the lower box shows functions enriched in control compared with Leaf 0.5 with top 10 p-value. U: Unclassified, HD: Human Diseases, GIP: Genetic Information Processing.

Performance analysis

In the present study, body weight, bone strength, and IBD were measured. The Leaf 0.3 and Leaf 0.5 groups showed higher body weights (P-value: 0.001 and 0.052, respectively) compared with the control group (S4 Fig). Bone strength and IBD showed higher levels in the Leaf 0.3 and Leaf 0.5 groups.

Discussion

This study demonstrated the effect of A. hookeri on gut microbiome, especially in the cecum of broiler chicken. In this study, we fed different feed supplements including A. hookeri to six groups of 1,200 broiler chickens, each group comprising 200 chickens: Control, CS, Leaf 0.3, Leaf 0.5, Root 0.3 and Root 0.5. Four chickens from each of the six groups with their weights similar to the average weight of the group were selected. Twenty-four samples from six groups were used for sequencing. The impact of Leaf 0.5 on the altered gut microbiome in this study may corroborate our previous study, which highlighted improved growth traits in Leaf 0.5. Based on multiple analysis of gut microbiome and phenotype of broiler chickens, this study provides deeper insight into the relationship between the intake of A. hookeri Leaf, microbial communities and growth performance.

The remarkable effect of leaf on microbiome is attributed to the abundance of pharmacologically active components contained in leaves. Previous studies regarding A. hookeri compared the concentrations of different ingredients in leaf with those of the root. Compared with the root, the leaf contains a higher number of polyphenols, estimated by the amount of total phenolics and flavonoids [15]. Polyphenol is an antioxidant that potentially prevents diseases related to oxidative stress, including cancer and cardiovascular diseases [29]. A large proportion (~90%) of absorbable polyphenols are digested by gut microbiome rather than the digestive enzymes in the small intestine [30]. Microbial degradation of polyphenols generates intermediates including aglycones that promote various aromatic acid metabolites [31]. The altered metabolite composition may alter the prebiotic effects of microrganisms such as antimicrobial activities against pathogens [32]. Especially, the reduction of bacteria was observed only in chickens exposed to leaves, which showed higher levels of total phenolics (240.4–276.6 mg gallic acid equivalents/100 g) compared with the roots [15]. In broiler chickens, polyphenol-rich grapes showed increased Enterococcus levels but decreased levels of Clostridium [21].The polyphenols in A. hookeri might play an important role in modulating microorganism composition, which explains the presence of unique microbial communities in the guts of chickens fed with polyphenol-rich leaves.

The altered abundance of bacteria following A. hookeri leaf supplementation occurs at the generic level. Among eight leaf-associated genera, the abundance of Parabacteroides was increased in the Leaf 0.5 group. Parabacteroides are obligatory anaerobic bacteria that degrade saccharides, forming acetate and succinate as the major end-products [33]. Except for Parabacteroides, the abundance of A. hookeri-associated genera decreased. The reduction in the abundance of most microbiomes may be associated with the antibacterial effect of A. hookeri leaf. The decrease in bacterial concentrations may be attributed to allicin, which accounts for the spicy flavor of A. hookeri. Allicin is an organosulfur compound with characteristic antibacterial activity against a wide range of microorganisms including Staphylococcus and Pseudomonas in several studies [23,34]. Its antibacterial activity is attributed to its chemical reaction with thiol groups of enzymes that influence the metabolism of cysteine proteinase activity related to bacterial virulence [35]. However, the mechanisms of antibacterial activity of A. hookeri are not clear. Therefore, further evidence is needed to establish the relationship between the decreased abundance of microorganisms and the antibacterial activity of A. hookeri.

The effects of A. hookeri on crucial phenotypes of broiler chickens were investigated, given the importance of growth trait enhancement without antibiotics for growth promotion (AGPs) and to decrease the risk of antibiotic resistance [36]. Other studies investigated feed supplements using natural foods including extracts from herb species, which enhanced poultry health by improving immunity and protecting chickens from avian diseases [3744]. Our previous study has shown that broiler chickens supplemented with A. hookeri show improved growth performance [22]. In the present study, a subset of samples from our previous study was used [45]. The Leaf 0.3 and Leaf 0.5 groups showed higher body weights (P-value: 0.001 and 0.052, respectively) compared with the control group (S4 Fig). To determine whether the microbiome was related to greater body weight in chickens exposed to A. hookeri leaves and to identify the genera associated with body weights, the abundance of genera was correlated with body weight. Notably, the genera showing positive (or negative) correlation with body weight were relatively abundant (or depleted) in Leaf 0.3 and Leaf 0.5 groups, suggesting that alterations in microbiome induced by leaf exposure may affect the body weight. Specific genera related to body weight are known to be related to diet or energy metabolism in other studies. For example, Bacillus that showed negative correlation with body weight was associated with feed efficiency in broiler chicks [46]. Clostridium sensustricto 1 showed a positive correlation with body weight. Family Clostridiaceae is known to induce weight gain in rex rabbits [47]. The association between increased body weight and microbiome is also supported by functional analysis. Results of functional analysis revealed that the chickens in Leaf 0.5 group showed enriched carbohydrate metabolism, which increased the body weight. In summary, the correlation between body weight and enrichment of carbohydrate metabolism suggests that altered communities of microorganisms induced by A. hookeri may alter the body weight.

The association between microbiome and other traits including bone strength and IBD antibody was also determined. Bone strength was examined because several bacteria improved calcium absorption [48]. IBD antibody was investigated as an index of immune system related to microbiome [24]. Among five genera associated with bone strength, none of them was correlated with bone strength in previous studies. However, the genera associated with IBD antibody were consistent with or contrary to previous metagenome studies related to immune system or IBD. Lachnoclostridium and Ruminococcaceae groups that were positively and negatively correlated with IBD antibody, respectively, were also involved in the inoculation of strongly virulent IBD virus in broiler chickens [49]. This finding indicates that these genera are strongly linked to the regulation of immune system.

Parasutterella, which showed a positive correlation with bone strength was also positively correlated with IBD. Parasutterella showed positive correlation with irritable bowel syndrome in a previous study [8]. However, the role of Parasutterella in gut pathophysiology has yet to be discovered. We speculated that the association with bone strength and IBD in common genera might be explained by the relationship between immune and bone cells. The interaction is mediated via circulating blood cells containing T and B cells in bone marrow [28]. T and B cells play important roles in cell-mediated immunity to regulate bone resorption and bone formation by producing large amounts of cytokines [50], which explains the connection between bone and immune cells. A mouse study has revealed that gut microbiota regulate bone mass and immune status [51]. Despite the association between specific genera and both traits, microorganisms known to control both bone mass and immune system were poorly detected. Thus, the genera detected in this study may provide a clue for this interaction. The small sample size is one of the study limitations; however, this is the first study to investigate the effect of A. hookeri on gut microbiome, despite several studies reporting its health benefits. Further studies are needed to determine the role of these genera in the interaction with immune system and bone strength.

In conclusion, our results showed the degree of alteration based on supplementation of A.hookeri, especially its leaf. The abundance of microorganisms was decreased in chickens exposed to A. hookeri leaves indicating that the leaf has a distinct effect on microbial communities. We also detected specific genera related to body weight, bone strength, and IBD antibody known to be important for productivity of broiler chickens. Therefore, the health benefit of A. hookeri in broiler chicken is mediated via its microbiome, suggesting that A. hookeri is a potential feed supplement for broiler chickens.

Materials and methods

Sample collection

Experimental protocol and procedures were approved by the Small Animal Care and Use Committee of the National Institute of Agricultural Sciences (NAS201707). A total of 1200 male broiler chickens (Arbor Acres broilers) were grown for 35 days. They were divided into six groups (n = 200 chickens/group): Control, CS, Leaf 0.3, Leaf 0.5, Root 0.3, and Root 0.5. All groups were freely fed with a basal diet (crude protein (CP) 22%, metabolic energy (ME) 3,100 kcal/kg for 0–3 weeks; and CP 20%, ME 3,150 kcal/kg for 3–5 weeks). A diet containing 0.05% Commercial Xtract (ML Co, Seoul, Korea) was used in the CS group. A. hookeri leaf or root powder (0.3% or 0.5%) was added to Leaf 0.3, Leaf 0.5, Root 0.3, and Root 0.5 groups. The different powders of A.hookeri were prepared after freeze-drying and grinding. Four chickens in each of the six groups similar to the average group weight were selected. Thus, a total of 24 samples (four samples from each of the six groups) were used for sequencing.

DNA extraction and Illumina Sequencing

Cecal samples were used for DNA extraction using AccuPrep Stool DNA Extraction Kit following the manufacturer’s instructions. The V3 and V4 regions of the 16S rRNA genes were PCR-amplified from the microbial genomic DNA. The DNA quality was determined using PicoGreen and Nonodrop methods. The input gDNA (10 ng) was PCR-amplified using the barcoded fusion primers 341F/805R (341F: 5’ CCTACGGGNGGCWGCAG 3, 805R: 5’ GACTACHVGGGTATCTAATCC 3’). The final purified product was quantified using qPCR according to the qPCR Quantification Protocol Guide (KAPA Library Quantification kits for Illumina Sequencing platforms) and qualified using the LabChip GX HT DNA High Sensitivity Kit (PerkinElmer, Massachusetts, USA). The 300 paired-end sequencing reaction was performed on MiSeq platform (Illumina, San Diego, USA). The sequencing data were deposited into the Sequence Read Archive (SRA) of NCBI (http://www.ncbi.nlm.nih.gov/sra) and accessed via accession number SRP151247.

Taxonomic analysis

De-multiplexed paired-end reads were merged with PEAR [52]. Pre-processed reads were analyzed using QIIME2 version 2017.12. We used DADA2 software package [53] implemented in QIIME2 to model and correct Illumina-sequenced FASTAQ files by removing chimeras using “consensus” method. QIIME2 q2-feature-classifier plugin was trained on a Silva database (Release 128) for 99% OTU full-length sequences.

Alpha and beta-diversity analyses were performed with q2-diversity plugin in QIIME2 at a sampling depth of 1000. Weighted Unifrac distance matrix was used for permutation multivariate analysis of variance (PERMANOVA) and PCoA plots. PERMANOVA was performed with 999 permutations to weighted UniFrac distance matrix using Adonis in R package ‘vegan’ [54].

Identification of differentially abundant microbiomes (DAM)

Trimmed Mean of M values (TMM) were obtained to adjust for different library sizes using edgeR [55]. Statistical tests were performed under generalized linear model (GLM) considering OTU counts as negative binomial distribution. To compare the goodness-of-fit of two models, the log-likelihood ratio was calculated. In the statistical test, the false discovery rate (FDR) was used to adjust for multiple testing errors with a significance level of 5% [56].

Performance analysis

In the present study, body weight, bone strength, and IBD antibody level of experimental chicken were measured at 5 weeks of age [45]. Four chickens in each of the six groups similar to the average group weight were selected for the Performance analysis. Thus, a total of 24 samples (four samples from each of the six groups) were used for bone strength and IBD antibody level of blood collected from heart. Tibia strength was measured using instron (Model 3342, Inatron Universal Testing Machine, Instron Corp., Norwood, MA, USA). Effects of A. hookeri on antibody titer against IBD in growing chickens were evaluated by Hemmagglutination inhibition test (HI test).

Statistical analysis of growth traits

The Student’s t-test was used to compare the growth traits between groups. The correlation between microbiota and growth traits was determined via Spearman correlation between TMM values of each sample and growth traits (body weight, bone strength and IBD antibody). The abundance (TMM value) of significantly correlated genera was visualized in a heat-map using pheatmap R package.

PICRUSt analysis and statistical comparison of functions between groups

Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict functional profile of microbiota [57]. Since PICRUSt uses a closed reference OTU picking based on Greengenes database (version 13.5.), the features assigned to Greengenes databases were used. The abundance of functions in Control was compared to that in Leaf 0.5 using Wilcoxon rank-sum test.

Supporting information

S1 Table. Results of PERMANOVA of pair-wise test for combinations groups.

(PDF)

S1 Fig. Shannon index and observed OTUs in six groups.

In Shannon index, a significant difference was observed between Leaf 0.3 and Root 0.3 group compared with CS (P = 0.02). In the observed OTU, Leaf 0.3 differed significantly from CS (P = 0.02).

(TIF)

S2 Fig. Phylum level composition.

Bar plots represent the percentage (%) of average abundance among groups.

(JPG)

S3 Fig. Predicted microbial functions deficient in Leaf 0.5.

Functions were predicted by PICRUSt. All functions enriched in Control compared with Leaf 0.5 are presented (P-value < 0.05). Terms are separated into upper and lower boxes because of scale.

(TIF)

S4 Fig. Body weight, bone strength, and IBD antibody of broiler chickens.

Leaf 0.3 and Leaf 0.5 showed higher body weight (P-value: 0.001 and 0.052, respectively) compared with the control group.

(TIF)

Acknowledgments

The authors appreciate Sung-Moon Jo for assistance with the care of chickens and C&K genomics for helping sample analysis, and thank Dr. You-Suk Kim for his critical review.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This research was fully supported by the fund of Agriculture Science & Technology Development (PJ01178705, PJ01327901) from National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea. The fund was used in this study design, data collection and analysis, or preparation of the manuscript. Bong-Sang Kim received support in the form of a salary from C&K genomics. Seung-Hwan Kim and Sang-Hyun Kang received support in the form of salaries from BHNBIO (KYOCHON F&B CO). The specific roles of the authors are articulated in the ‘author contributions’ section.

References

  • 1.Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014;7:17–44. 10.3390/nu7010017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim JE,Lillehoj HS, Hong YH, Kim GB, Lee SH, Lillehoj EP, et al. Dietary Capsicum and Curcuma longa oleoresins increase intestinal microbiome and necrotic enteritis in three commercial broiler breeds. Res Vet Sci. 2015;102:150–1508. 10.1016/j.rvsc.2015.07.022 [DOI] [PubMed] [Google Scholar]
  • 3.Gerritsen J, Smidt H, Rijkers GT, Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6: 209–240. 10.1007/s12263-011-0229-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ferrario C, Statello R, Carnevali L, Mancabelli L, Milani C, Mangifesta M, et al. How to Feed the Mammalian Gut Microbiota: Bacterial and Metabolic Modulation by Dietary Fibers. Front Microbiol. 2017;8: 1749 10.3389/fmicb.2017.01749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104:S1–S63. 10.1017/S0007114510003363 [DOI] [PubMed] [Google Scholar]
  • 6.Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16:341–352, 10.1038/nri.2016.42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K,et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:73, 10.1186/s12967-017-1175-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kim NS, Choi BK, Lee SH, Jang HH, Kim JB, Kim HR, et al. Effects of Allium hookeri on glucose metabolism in type II diabetic mice.Kor JPharmacogn. 2015;46:78–83. [Google Scholar]
  • 9.Lee SH,Kim NS, Choi BK, Jang HH, Kim JB, Lee YM, et al. Effects of Allium hookeri on lipid metabolism in type II diabetic mice. Kor J Pharmacogn. 2015;46:148–153. [Google Scholar]
  • 10.Sengupta A, Ghosh S, Bhattacharjee S. Allium vegetables in cancer prevention: an overview. Asian Pac J Cancer P. 2004;5: 237–245. [PubMed] [Google Scholar]
  • 11.Bianchini F, Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect. 2001;109: 893–902. 10.1289/ehp.01109893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nencini C,Cavallo F, Capasso A, Franchi GG, Giorgio G, Micheli L. Evaluation of antioxidative properties of Allium species growing wild in Italy. Phytother Res. 2007;21:874–878. 10.1002/ptr.2168 [DOI] [PubMed] [Google Scholar]
  • 13.Kim CH, Lee MA, Kim TW, Jang JY, Kim HJ. Anti-inflammatory effect of Allium hookeri root methanol extract in LPS-induced RAW264. 7 cells.J Korean Soc Food Sci Nutr. 2012;41: 1645–1648. 10.3746/jkfn.2012.41.11.1645 [DOI] [Google Scholar]
  • 14.Lee KW, Kim YS, Park PJ, Jeong JH. Comparison of Effect of Water and Ethanolic Extract from Roots and Leaves of Allium hookeri. J Korean Soc Food Sci Nutr. 2014;43:1808–1816. 10.3746/jkfn.2014.43.12.1808 [DOI] [Google Scholar]
  • 15.Hwang JS, Lee BH, An X, Jeong HR, Kim YE, Lee Ii, et al. Total Phenolics, Total Flavonoids, and Antioxidant Capacity in the Leaves, Bulbs, and Roots of Allium hookeri. Korean J Food Sci Technol. 2015;47:261–266. 10.9721/kjfst.2015.47.2.261 [DOI] [Google Scholar]
  • 16.Lee YS, Lee SH, Jeong MS, Kim JB, Jang HH, Choe JS, et al. In vitro analysis of the immunomodulating effects of Allium hookeri on lymphocytes,macrophages, and tumour cells. J Poult Sci. 2017;54:142–148. 10.2141/jpsa.0160108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Roh SS, Kwon OJ, Yang JH, Kim YS, Lee SH, Jin JS, et al. Allium hookeri root protects oxidative stress-induced inflammatory responses and beta-cell damage in pancreas of streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2016;16: 63 10.1186/s12906-016-1032-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lee Y, Lee SH, Gadde UD, Oh ST, Lee SJ, Lillehoj HS. Dietary Allium hookeri reduces inflammatory response and increases expression of intestinal tight junction proteins in LPS-induced young broiler chicken. Res Vet Sci. 2017;112:149–155. 10.1016/j.rvsc.2017.03.019 [DOI] [PubMed] [Google Scholar]
  • 19.Song EY, Pyun CW, Hong GE, Lim KW, Lee CH. Effect of addition of Allium hookeri on the quality of fermented sausage with meat from sulfur fed pigs during ripening. Korean J Food Sci Anim Resour. 2014;34: 263–272. 10.5851/kosfa.2014.34.3.263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kim JH, Ju MG, Yeon SJ, Hong GE, Lee CH. Effect of Allium hookeri and whey powder in diet of pigs on physicochemical characteristics and oxidative stability of pork. Ital J AnimSci. 2017;1:9–17. 10.1080/1828051X.2017.1326856 [DOI] [Google Scholar]
  • 21.Viveros A. Chamorro S, Pizarro M, Arija I, Centeno C, Brenes A. Effects of dietary polyphenol-rich grape products on intestinal microflora and gutmorphology in broiler chicks. Poult Sci. 2011;90:566–578. 10.3382/ps.2010-00889 [DOI] [PubMed] [Google Scholar]
  • 22.Lee EB, Lee SH, Kim SH, Kang SH, Lee KW, Kim DH, et al. Effects of Dietary Allium Hookeri on Growth and Blood Biochemical Parameters in Broiler Chickens. Kor J Pharmacogn. 2018;49:1–6. [Google Scholar]
  • 23.Fujisawa H, Watanabe K, Suma K, Origuchi K, Matsufuji H, Seki T, et al. Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds. Biosci Biotechnol Biochem. 2009;73:1948–1955. 10.1271/bbb.90096 [DOI] [PubMed] [Google Scholar]
  • 24.Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways incolonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3: 448 10.3389/fphys.2012.00448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lee YK. Effects of diet on gut microbiota profile and the implications for health and disease. Biosci Microbiota Food Health. 2013;32:1–12. 10.12938/bmfh.32.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ur Rahman S, Khan S, Chand N, Sadique U, Khan RU. In vivo effects of Allium cepa L. on the selected gut microflora and intestinal histomorphology in broiler. Acta Histochem. 2017;119:446–450. 10.1016/j.acthis.2017.04.004 [DOI] [PubMed] [Google Scholar]
  • 27.Ravussin Y. Koren O, Spor A, LeDuc C, Gutman R, Stombaugh J, et al. Responses of gut microbiota to diet composition and weight loss in lean and obesemice. Obesity (Silver Spring). 2012;20:738–747. 10.1038/oby.2011.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.D'Amelio P, Sassi F. Gut Microbiota, Immune System, and Bone. Calcif Tissue Int. 2018;102:415–425. 10.1007/s00223-017-0331-y [DOI] [PubMed] [Google Scholar]
  • 29.Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. The Am J Clin Nutr. 2004;79: 727–747. 10.1093/ajcn/79.5.727 [DOI] [PubMed] [Google Scholar]
  • 30.Edwards C, Havlik J,Cong W, Mullen W, Preston T, Morrison DJ, et al. Polyphenols and health: Interactions between fibre, plant polyphenols and the gut microbiota.Nutr Bull. 2017;42:356–360. 10.1111/nbu.12296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Scalbert A, Morand C, Manach C, Rémésy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother. 2002; 56: 276–282. 10.1016/s0753-3322(02)00205-6 [DOI] [PubMed] [Google Scholar]
  • 32.Lee HC, Jenner AM, Low CS, Lee YK. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol. 2006;157:876–884. 10.1016/j.resmic.2006.07.004 [DOI] [PubMed] [Google Scholar]
  • 33.Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol. 2006;56:1599–1605. 10.1099/ijs.0.64192-0 [DOI] [PubMed] [Google Scholar]
  • 34.Cutler R, Wilson P. Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus. Br J Biomed Sci. 2004;61:71–74. 10.1080/09674845.2004.11732646 [DOI] [PubMed] [Google Scholar]
  • 35.Reiter J, Levina N, van der Linden M, Gruhlke M, Martin C, Slusarenko AJ. Diallylthiosulfinate (Allicin), a Volatile Antimicrobial from Garlic (Allium sativum), Kills Human Lung Pathogenic Bacteria, Including MDR Strains, as a Vapor. Molecules. 2017; 22:E1711 10.3390/molecules22101711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Cervantes HM. Antibiotic-free poultry production: is it sustainable? J Appl PoultRes. 2015;24:91–97. 10.3382/japr/pfv006 [DOI] [Google Scholar]
  • 37.Kim DK, Lillehoj HS, Lee SH, Jang SI, Lillehoj EP, Bravo D. Dietary Curcuma longa enhances resistance against Eimeria maxima and Eimeria tenella infections in chickens. Poult Sci. 2013;92:2635–2643. 10.3382/ps.2013-03095 [DOI] [PubMed] [Google Scholar]
  • 38.Lillehoj HS, Kim DK, Bravo DM, Lee SH. Effects of dietary plant-derived phytonutrients on the genome-wide profiles and coccidiosis resistance in the broiler chickens. BMC Proc. 2011;Suppl 34 10.1186/1753-6561-5-S4-S34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lee SH, Lillehoj HS, Jang SI, Lee KW, Bravo D, Lillehoj EP. Effects of dietary supplementation with phytonutrients on vaccine-stimulated immunity against infection with Eimeria tenella. Vet Parasitol. 2011;181:97–105. 10.1016/j.vetpar.2011.05.003 [DOI] [PubMed] [Google Scholar]
  • 40.Lee S, Lillehoj HS, Park DW, Jang SI, Morales A, García D, et al. Induction of passive immunity in broiler chickens against Eimeria acervulina by hyperimmune egg yolk immunoglobulin Y. Poult Sci. 2009;88:562–566. 10.3382/ps.2008-00340 [DOI] [PubMed] [Google Scholar]
  • 41.Kim DK, Lillehoj HS, Lee SH, Lillehoj EP, Bravo D. Improved resistance to Eimeriaacervulina infection in chickens due to dietary supplementation with garlic metabolites. Br J Nutr. 2013;109: 76–88. 10.1017/S0007114512000530 [DOI] [PubMed] [Google Scholar]
  • 42.Lee K, Lillehoj HS, Jang SI, Lee SH, Bautista DA, Siragusa GR. Effect of Bacillus subtilis-based direct-fed microbials on immune status in broiler chickens raised on fresh or used litter. Asian-Australas J Anim Sci. 2013;26:1592–1597. 10.5713/ajas.2013.13178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lee SH, Lillehoj HS, Jang SI, Lee KW, Park MS, Bravo D,et al. Cinnamaldehyde enhances in vitro parameters of immunity and reduces in vivo infection against avian coccidiosis. Br J Nutr. 2011;106:862–869. 10.1017/S0007114511001073 [DOI] [PubMed] [Google Scholar]
  • 44.Lee SH, Lillehoj HS, Jang SI, Lillehoj EP, Min W, Bravo DM. Dietary supplementation of young broiler chickens with Capsicum and turmeric oleoresins increases resistance to necrotic enteritis. Br J Nutr. 2013;110:840–847. 10.1017/S0007114512006083 [DOI] [PubMed] [Google Scholar]
  • 45.Lee EB, Lee SH, Kim SH, Kang SH, Lee KW, et al. Effects of Dietary Allium hookeri on Growth and Blood Biochemical Parameters in Broiler Chickens. Pharmacogn. 2018; 49:1–6. [Google Scholar]
  • 46.Santoso U, Tanaka K, Ohtani S. Effect of dried Bacillus subtilis culture on growth, body composition and hepatic lipogenic enzyme activity in female broiler chicks. Br J Nutr. 1995;74:523–529. 10.1079/BJN19950155 [DOI] [PubMed] [Google Scholar]
  • 47.Zeng B, Han S, Wang P, Wen B, Jian W, Guo W, et al. The bacterial communities associated with fecal types and body weight of rex rabbits. Sci Rep. 2015;5: 9342 10.1038/srep09342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ohlsson C, Sjögren K. Effects of the gut microbiota on bone mass. Trends Endocrinol Metab. 2015;26:69–74. 10.1016/j.tem.2014.11.004 [DOI] [PubMed] [Google Scholar]
  • 49.Li L, Kubasová T, Rychlik I, Hoerr FJ, Rautenschlein S. Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition. PloS One. 2018;13:e0192066 10.1371/journal.pone.0192066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Pacifici R. The immune system and bone. Arch Biochem Biophys. 2010;503: 41–53. 10.1016/j.abb.2010.05.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012;27:1357–1367. 10.1002/jbmr.1588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics. 2014;30:614–620. 10.1093/bioinformatics/btt593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Callahan B J, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–583. 10.1038/nmeth.3869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O 'hara RB. Package ‘vegan’. 2019. Available from: https://cran.r-project.org, https://github.com/vegandevs/vegan [Google Scholar]
  • 55.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. 10.1093/bioinformatics/btp616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 1995;57:289–300. 10.1111/j.2517-6161.1995.tb02031.x [DOI] [Google Scholar]
  • 57.Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31:814–821. 10.1038/nbt.2676 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Juan J Loor

15 Aug 2019

PONE-D-19-17223

Effects of Allium hookeri leaf on gut microbiome related to growth performance of young broiler chickens

PLOS ONE

Dear Dr Lee,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Sep 29 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Financial Disclosure section:

This work was supported by Agriculture Science & Technology Development (PJ01178705, PJ01327901) funded by Rural Development Administration, Republic of Korea. The fund was used in study design, data collection and analysis, or preparation of the manuscript.

We note that one or more of the authors are employed by a commercial company: C&K genomics and BHNBIO.

1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article has scientific merit. However, it needs some adjustments and some clarification.

The title should contain the word "root", not just leaf

Important information is missing from the summary as the main bacteria found, what were the main changes with the treatments. Still in the summary, the authors report that the main changes are involved with the 0.5% level, but I disagree, throughout the work it is possible to realize that 0.3% has a great impact on the results.In the conclusion of the summary it must be clear that the effect was of the leaf.

At the end of the introduction the goal needs to be clearer, it went far beyond the profile of the microbiota. Several correlations were presented that were also objective.

In line 128, the authors use the term microbes, the advised term is the microorganisms please note this throughout the text.

Data on the composition (profile) at the genus level should be showed for all treatments this will make it easier to understand figures 2b and 2c.

In the discussion, between lines 232 and 238 the authors report that A.hookeri has effect as a prebiotic, however, they do not make it clear.

But if it has prebiotic action what would be the leaf component responsible for this effect?And how much of this compound is in the leaf?

In line 251 boiler = broiler

In line 256 the authors report the following sentence "In the present study a subset of samples from our previous study was used" two points here are crucial. First: the methodology for performance analysis should be in the material and methods as well as bone and IBD results should be presented. What statistical analyzes were used for these data? Second: If these performance data were performed in a separate experiment; Correlation between the data is not feasible because we know that the microbiota is variable.

The discussion about the microbiota and its effect on performance, ibd and bones was short. We know that when the immune system is stimulated the impact on performance is negative. If Parasutterella stimulates the immune system, how can it be treated for performance?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Priscila de Oliveira Moraes

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Juan J Loor

9 Dec 2019

Effects of Allium hookeri on gut microbiome related to growth performance in young broiler chickens

PONE-D-19-17223R1

Dear Dr. Lee,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Juan J Loor

23 Dec 2019

PONE-D-19-17223R1

Effects of Allium hookeri on gut microbiome related to growth performance in young broiler chickens

Dear Dr. Lee:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Juan J Loor

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Results of PERMANOVA of pair-wise test for combinations groups.

    (PDF)

    S1 Fig. Shannon index and observed OTUs in six groups.

    In Shannon index, a significant difference was observed between Leaf 0.3 and Root 0.3 group compared with CS (P = 0.02). In the observed OTU, Leaf 0.3 differed significantly from CS (P = 0.02).

    (TIF)

    S2 Fig. Phylum level composition.

    Bar plots represent the percentage (%) of average abundance among groups.

    (JPG)

    S3 Fig. Predicted microbial functions deficient in Leaf 0.5.

    Functions were predicted by PICRUSt. All functions enriched in Control compared with Leaf 0.5 are presented (P-value < 0.05). Terms are separated into upper and lower boxes because of scale.

    (TIF)

    S4 Fig. Body weight, bone strength, and IBD antibody of broiler chickens.

    Leaf 0.3 and Leaf 0.5 showed higher body weight (P-value: 0.001 and 0.052, respectively) compared with the control group.

    (TIF)

    Attachment

    Submitted filename: Responses to reviewers_2019 10 31-5.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES